Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.
Pericàs JM, Di Prospero NA, Anstee QM, Mesenbrinck P, Kjaer MS, Rivera-Esteban J, Koenig F, Sena E, Pais R, Manzano R, Genescà J, Tacke F, Ratziu V; EU-PEARL NASH Investigators. Pericàs JM, et al. Among authors: genesca j. Aliment Pharmacol Ther. 2023 May;57(9):948-961. doi: 10.1111/apt.17456. Epub 2023 Mar 14. Aliment Pharmacol Ther. 2023. PMID: 36918740 Review.
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes.
Rivera-Esteban J, Pons M, Planas A, Manzano-Nuñez R, Hernández C, Simó-Servat O, Bañeras J, Soler MJ, Seron D, Boixadera A, Augustin S, Simó R, Ferreira-González I, Genescà J, Pericàs JM; PRECISED consortium. Rivera-Esteban J, et al. Among authors: genesca j. Gastroenterol Hepatol. 2023 Nov;46(9):682-691. doi: 10.1016/j.gastrohep.2022.11.001. Epub 2022 Nov 23. Gastroenterol Hepatol. 2023. PMID: 36435379 English, Spanish.
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Pons M, Rivera-Esteban J, Ma MM, Davyduke T, Delamarre A, Hermabessière P, Dupuy J, Wong GL, Yip TC, Pennisi G, Tulone A, Cammà C, Petta S, de Lédinghen V, Wong VW, Augustin S, Pericàs JM, Abraldes JG, Genescà J. Pons M, et al. Among authors: genesca j. Clin Gastroenterol Hepatol. 2023 Aug 11:S1542-3565(23)00626-2. doi: 10.1016/j.cgh.2023.08.004. Online ahead of print. Clin Gastroenterol Hepatol. 2023. PMID: 37573987
Clinical practice guidelines of the Catalan Society of Gastroenterology about hepatic elastography 2022.
Carrión JA, Graupera I, Vergara M, Morillas RM, Pericàs JM, Poca M, Amador A, Fernández R, Monllor T, Muñoz L, Bartres C, Genescà J, Ginés P, Forns X. Carrión JA, et al. Among authors: genesca j. Gastroenterol Hepatol. 2023 Nov;46(9):732-746. doi: 10.1016/j.gastrohep.2022.11.005. Epub 2022 Nov 23. Gastroenterol Hepatol. 2023. PMID: 36435378 Free article. English, Spanish.
Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells.
Gil M, Khouri L, Raurell I, Rafael D, Andrade F, Abasolo I, Schwartz S Jr, Martínez-Gómez M, Salcedo MT, Pericàs JM, Hide D, Wei M, Metanis N, Genescà J, Martell M. Gil M, et al. Among authors: genesca j. Pharmaceutics. 2023 Oct 14;15(10):2463. doi: 10.3390/pharmaceutics15102463. Pharmaceutics. 2023. PMID: 37896223 Free article.
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Nicoară-Farcău O, Lozano JJ, Alonso C, Sidorova J, Villanueva C, Albillos A, Genescà J, Llop E, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Tantău M, Thompson M, Perez-Campuzano V, Baiges A, Turon F, Hernández-Gea V, Abraldes JG, Tapias EA, Torres F, Bosch J, García-Pagán JC; PreDesCI Study Investigators. Nicoară-Farcău O, et al. Among authors: genesca j. Hepatology. 2023 Jun 1;77(6):2052-2062. doi: 10.1097/HEP.0000000000000316. Epub 2023 Feb 23. Hepatology. 2023. PMID: 36811400 Clinical Trial.
187 results